Article
Changes in cellular virus load and zidovudine resistance of syncytium-inducing and non-syncytium-inducing human immunodeficiency virus populations under zidovudine pressure: a clonal analysis.
The Journal of infectious diseases - 1 Oct 1996
van 't Wout A B, de Jong M D, Kootstra N A, Veenstra J, Lange J M, Boucher C A, Schuitemaker H
Abstract excerpt
Zidovudine treatment preferentially benefits persons with only non-syncytium-inducing (NSI) human immunodeficiency virus type 1 (HIV-1) variants. To understand this differential efficacy, changes in cellular virus load, clonal composition of HIV-1 populations, and development of resistance-confer...
Topics
- Acquired Immunodeficiency Syndrome
- Anti-HIV Agents
- Drug Resistance
- HIV-1
- Humans
- Male
- Mutation
- Zidovudine
